Seer reported revenue of $3.1 million for the first quarter of 2024, a 24% decrease compared to the prior year. The company's net loss was $20.7 million. They ended the quarter with $359.2 million in cash, cash equivalents and investments.
Seer achieved revenue of $3.1 million for the first quarter of 2024.
The Seer Technology Access Center (STAC) program expanded to Europe.
The power of the Proteograph Product Suite was further validated with three peer-reviewed publications.
Seer authorized an open-market share repurchase program of up to $25 million.
Seer now expects full year 2024 revenue to be in the range of $16 million to $18 million, which is in line with full year 2023 revenue.
Visualization of income flow from segment revenue to net income
Analyze how earnings announcements historically affect stock price performance